Related Experiment Video
Updated: May 11, 2026
08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
9.4K
Left Ventricular Assist Device Versus Cardiac Implantable Electronic Device Infections: Distinct Entities, Distinct
Supavit Chesdachai1, Larry M Baddour1,2, Daniel C DeSimone1,2
1Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Summary
Distinguishing infections of left ventricular assist devices and cardiac implantable electronic devices is crucial. Tailored, device-specific suppressive antibiotic therapy (SAT) strategies are needed due to significant differences in infection characteristics.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Device Technology
Background:
- Infections associated with cardiac implantable electronic devices (CIEDs) and left ventricular assist devices (LVADs) present distinct challenges.
- Understanding these differences is critical for effective patient management and treatment outcomes.
Purpose of the Study:
- To highlight the necessity of differentiating between CIED and LVAD infections.
- To emphasize the need for tailored suppressive antibiotic therapy (SAT) strategies specific to each device type.
Main Methods:
- This commentary reviews and contrasts key aspects of CIED and LVAD infections.
- Comparative analysis of incidence, microbiology, clinical presentation, and extraction feasibility is discussed.
Main Results:
- LVAD infections and CIED infections exhibit significant differences in their incidence and causative microorganisms.
- Clinical presentations and the feasibility of device extraction vary considerably between LVAD and CIED infections.
Conclusions:
- A clear distinction between LVAD and CIED infections is warranted for appropriate clinical decision-making.
- Device-specific SAT approaches are essential for optimizing treatment and preventing complications associated with cardiac device infections.
Keywords:
cardiac implantable electronic device infectionsdevice extractionleft ventricular assist device infectionsoutcomessuppressive antibiotic therapyMore Related Videos
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Endocarditis I: Introduction
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
01:18Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...